Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antioxidants Continue To Show Benefits In AREDS Follow-Up

This article was originally published in The Tan Sheet

Executive Summary

The latest follow-up to the Age-Related Eye Diseases Study continues to show "beneficial effects" of antioxidants and zinc as therapy for age-related macular degeneration, according to Emily Y. Chew, the study chairwoman at the National Eye Institute

You may also be interested in...



Research & Development In Brief

Lutein, zeaxanthin slow AMD progression; omega-3s fight sickle cell diseases; aspirin link to AMD suggested; ibuprofen eases altitude sickness symptoms.

Research & Development In Brief

Lutein, zeaxanthin slow AMD progression; omega-3s fight sickle cell diseases; aspirin link to AMD suggested; ibuprofen eases altitude sickness symptoms.

Antioxidant Claims Oversimplify Nutrient Functions, Scientists Say

As antioxidant claims proliferate across the food and supplement industries, the complexity underlying antioxidant nutrients and their functions poses challenges for scientists, marketers and consumers.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel